Benzinga | Mar 23, 2021 04:03PM EDT

Aptose Biosciences Q4 EPS $(0.17) Misses $(0.14) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 30.77 percent decrease over losses of $(0.13) per share from the same period last year.